BERGAMO FRANCESCA

EUROPEAN
CURRICULUM VITAE
FORMAT
PERSONAL INFORMATION
Name
BERGAMO FRANCESCA
Address
ISTITUTO ONCOLOGICO VENETO
MEDICAL ONCOLOGY 1 UNIT
VIA GATTAMELATA 64
35128 PADOVA, ITALY
Telephone
+39-049-8215910
Fax
+39-049-8215900
E-mail
Nationality
Date of birth
[email protected]
Italian
AUGUST 20TH, 1981
WORK EXPERIENCE
• Dates (from – to)
• Name and address of employer
• Type of business or sector
• Occupation or position held
• Main activities and responsibilities
• Dates (from – to)
• Name and address of employer
• Type of business or sector
• Occupation or position held
• Main activities and responsibilities
• Dates (from – to)
• Name and address of employer
• Type of business or sector
• Occupation or position held
• Main activities and responsibilities
• Dates (from – to)
• Name and address of employer
• Type of business or sector
• Occupation or position held
• Main activities and responsibilities
Page 1 - Curriculum vitae of
[ Bergamo Francesca ]
October 2011-present
Medical Oncology 1 Unit
Istituto Oncologico Veneto, IRCCS, Padova
Public Hospital
Freelance Medical Oncologist with fixed-term contract
Medical Treatment of Cancer Patients and research activity in gastrointestinal cancer
August 2011 – September 2011
Medical Oncology 1 Unit
Istituto Oncologico Veneto, IRCCS, Padova
Public Hospital
Research Fellow (post-specialization)
Medical Treatment of Cancer Patients and research project on colorectal cancer.
November 2012 – February 2013
Medical Oncology
Azienda Ospedaliero Universitaria Pisana - Pisa (AIOM award for young oncologist)
Public Hospital
Fellow
Translational project “BRAF mutation in liver resected metastatic colorectal cancer patients”, clinical and research
activity.
July 2007 – July 2011
Medical Oncology
Istituto Oncologico Veneto, IRCCS, Padova
Public Hospital
Resident in Medical Oncology
Assistant in Medical Treatment of Cancer Patients and clinical research in solid tumors
For more information go to
www.cedefop.eu.int/transparency/
europa.eu.int/comm/education/index_en.html
eurescv-search.com/
RESEARCH EXPERIENCE
• Dates (from – to)
• Name and address of Organization
• Occupation or position held
• Main activities and responsibilities
2007- present
Industry Sponsored Trials or non- sponsored Academic trials
Co-Investigator for more than 45 trials (Industry-sponsored or Academic) dealing with colorectal cancer, bilio-pancreatic
cancer, gastric cancer, hepatocellular carcinoma, elderly patients and palliative cares
EDUCATION AND TRAINING
• Dates (from – to)
• Name and type of organisation providing
education and training
• Principal subjects/occupational
skills covered
• Title of qualification awarded
• Dates (from – to)
• Name and type of organisation providing
education and training
• Principal subjects/occupational
skills covered
• Title of qualification awarded
2011
Residency School in Medical Oncology
University of Padova
Medical management and molecular basis of solid tumors
Medical Oncology Specialty
2006
University of Padova
Medicine
Degree in Medicine (M.D.- Medical Doctor)
PERSONAL SKILLS
AND COMPETENCES
Acquired in the course of life and career
but not necessarily covered by formal
certificates and diplomas.
MOTHER TONGUE
ITALIAN
OTHER LANGUAGES
• Reading skills
• Writing skills
• Verbal skills
ORGANISATIONAL SKILLS
AND COMPETENCES
Coordination and administration of people,
projects and budgets; at work, in voluntary
work (for example culture and sports) and at
home, etc.
TECHNICAL SKILLS
AND COMPETENCES
With computers, specific kinds of equipment,
machinery, etc.
Page 2 - Curriculum vitae of
[ Bergamo Francesca ]
ENGLISH
EXCELLENT
VERY GOOD
VERY GOOD
MANAGEMENT OF CANCER PATIENTS WITHIN MULTIDISCIPLINARY TEAMS
WRITING OF RESEARCH PROJECTS
CONDUCTION OF CLINICAL TRIALS (PHASE II, III AND IV)
OFFICE PACKAGE
RESEARCHES IN PUBLIC DATABASES
For more information go to
www.cedefop.eu.int/transparency/
europa.eu.int/comm/education/index_en.html
eurescv-search.com/
ANNEXES
Scientific Publications
SCIENTIFIC PUBLICATIONS
SCIENTIFIC AFFILIATIONS
AWARDS
Scientific Publications (TOTAL IMPACT FACTOR=
, TOTAL H INDEX= )
1)
Koussis H, Scola A, Bergamo F, Tonello S, Basso U, Karahontzitis P, Chiarion-Sileni
V, Pasetto L, Ruol A, Loreggian L, Lora O, Bottin R, Marioni G, Donach M, Jirillo A.
Neoadjuvant carboplatin and vinorelbine followed by chemoradiotherapy in locally
advanced head and neck or oesophageal squamous cell carcinoma: a phase II study
in elderly patients or patients with poor performance status. Anticancer Res. 2008 MarApr;28(2B):1383-8.
2)
Aschele C, Bergamo F, Lonardi S. Chemotherapy for operable and advanced
colorectal cancer. Cancer Treat Rev. 2009 Oct;35(6):509-16. Epub 2009 May 29.
3)
Cappetta A, Bergamo F, Mescoli C, Lonardi S, Rugge M, Zagonel V. Hepatoid
adenocarcinoma of the colon: what should we target? Pathol Oncol Res. 2012
Jan;18(1):93-6. doi: 10.1007/s12253-011-9424-5. Epub 2011 Jun 12.
4)
Cappetta A, Lonardi S, Pastorelli D, Bergamo F, Lombardi G, Zagonel V. Advanced
gastric cancer (GC) and cancer of the gastro-oesophageal junction (GEJ): focus on
targeted therapies. Crit Rev Oncol Hematol. 2012 Jan;81(1):38-48.
5)
Argyriou AA, Cavaletti G, Briani C, Velasco R, Bruna J, Campagnolo M, Alberti P,
Bergamo F, Cortinovis D, Cazzaniga M, Santos C, Papadimitriou K, Kalofonos HP.
Clinical pattern and associations of oxaliplatin acute neurotoxicity: a prospective study
in 170 patients with colorectal cancer. Cancer. 2013 Jan 15;119(2):438-44.
6)
Briani C, Campagnolo M, Lucchetta M, Cacciavillani M, Dalla Torre C, Granata G,
Bergamo F, Lonardi S, Zagonel V, Cavaletti G, Ermani M, Padua L. Ultrasound
assessment of oxaliplatin-induced neuropathy and correlations with neurophysiologic
findings. Eur J Neurol. 2013 Jan;20(1):188-92.
7)
Lucchetta M, Lonardi S, Bergamo F, Alberti P, Velasco R, Argyriou AA, Briani C,
Bruna J, Cazzaniga M, Cortinovis D, Cavaletti G, Kalofonos HP. Incidence of atypical
acute nerve hyperexcitability symptoms in oxaliplatin-treated patients with colorectal
cancer. Cancer Chemother Pharmacol. 2012 Dec;70(6):899-902.
8)
Fornaro L, Lonardi S, Masi G, Loupakis F, Bergamo F, Salvatore L, Cremolini C,
Schirripa M, Vivaldi C, Aprile G, Zaniboni A, Bracarda S, Fontanini G, Sensi E, Lupi C,
Morvillo M, Zagonel V, Falcone A. FOLFOXIRI in combination with panitumumab as
first-line treatment in quadruple wild-type (KRAS, NRAS, HRAS, BRAF) metastatic
colorectal cancer patients: a phase II trial by the Gruppo Oncologico Nord Ovest
(GONO). Ann Oncol. 2013 Aug; 24(8):2062-7.
9)
Reni M, Cereda S, Milella M, Novarino A, Passardi A, Mambrini A, Di Lucca G, Aprile
G, Belli C, Danova M, Bergamo F, Franceschi E, Fugazza C, Ceraulo D, Villa E.
Maintenance sunitinib or observation in metastatic pancreatic adenocarcinoma: A
phase II randomised trial. Eur J Cancer. 2013 Jul 27. doi:pii: S0959-8049(13)00545-5.
10.1016/j.ejca.2013.06.041.
10) Campagnolo M, Lazzarini D, Fregona I, Cacciavillani M, Bergamo F, Parrozzani R,
Midena E, Briani C. Corneal confocal microscopy in patients with oxaliplatin-induced
peripheral neuropathy. J Peripher Nerv Syst. 2013 Sep;18(3):269-71.
Page 3 - Curriculum vitae of
[ Bergamo Francesca ]
For more information go to
www.cedefop.eu.int/transparency/
europa.eu.int/comm/education/index_en.html
eurescv-search.com/
11) Loupakis F, Cremolini C, Salvatore L, Masi G, Sensi E, Schirripa M, Michelucci A,
Pfanner E, Brunetti I, Lupi C, Antoniotti C, Bergamo F, Lonardi S, Zagonel V, Simi P,
Fontanini G, Falcone A. FOLFOXIRI plus bevacizumab as first-line treatment in BRAF
mutant metastatic colorectal cancer. Eur J Cancer. 2013 Oct 15. pii: S09598049(13)00840-X.
12) Bergamo F, Maruzzo M, Basso U, Montesco MC, Zagonel V, Gringeri E, Cillo U.
Neoadjuvant sirolimus for a large hepatic perivascular epithelioid cell tumor
(PEComa). World J Surg Oncol. 2014 Feb 27 ;12 :46.
13) Fornaro L, Cereda S, Aprile G, Di Girolamo S, Santini D, Silvestris N, Lonardi S, Leone
F, Milella M, Vivaldi C, Belli C , Bergamo F, Lutrino SE, Filippi R, Russano M, Vaccaro
V, Brunetti AE, Rotella V, Falcone A, Barbera MA, Corbelli J, Fasola G, Aglietta M,
Zagonel V, Reni M, Vasile E, Brandi G. Multivariate prognostic factors analysis for
second-line chemotherapy in advanced biliary tract cancer. Br J Cancer. 2014 Apr 8.
DOI: 10.1038/BJC.2014.190.
14) Bajetta E, Floriani I, Di Bartolomeo M, et al. for the ITACA-S (Intergroup Trial of
Adjuvant Chemotherapy in Adenocarcinoma of the Stomach trial) Study Group.
Randomized trial on adjuvant treatment with FOLFIRI followed by docetaxel and
cisplatin versus 5-fluorouracil and folinic acid for radically resected gastric cancer. Ann
Oncol. 2014 Apr 12.
Scientific affiliations
Awards
ITALIAN ASSOCIATION OF MEDICAL ONCOLOGY-AIOM
EUROPEAN SOCIETY OF MEDICAL ONCOLOGY-ESMO
2012 - AIOM
AWARD FOR YOUNG ONCOLOGIST FOR THE TRANSLATIONAL RESEARCH PROJECT “BRAF
MUTATION IN LIVER RESECTED METASTATIC COLORECTAL CANCER PATIENTS”.
PADUA,
APRIL 18, 2014
Page 4 - Curriculum vitae of
[ Bergamo Francesca ]
For more information go to
www.cedefop.eu.int/transparency/
europa.eu.int/comm/education/index_en.html
eurescv-search.com/

Download Report